Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil French

Showing results (201-210 of 211) with videos related to

Pageof 22
Sort By:
PLOS Global Public Health|March 24, 2023
Different clinical features in Malawian outpatients presenting with COVID-19 prior to and during Omicron variant dominance: A prospective observational studyMarah G Chibwana, Herbert W Thole, Cat Anscombe, et al.
Communications Biology|October 9, 2020
Bacterial genome-wide association study of hyper-virulent pneumococcal serotype 1 identifies genetic variation associated with neurotropismChrispin Chaguza, Marie Yang, Jennifer E Cornick, et al.
The New England Journal of Medicine|May 3, 2014
Diagnosis of childhood tuberculosis and host RNA expression in AfricaSuzanne T Anderson, Myrsini Kaforou, Andrew J Brent, et al.
American Journal of Respiratory and Critical Care Medicine|September 17, 2020
Experimental Human Pneumococcal Colonization in Older Adults Is Feasible and Safe, Not ImmunogenicHugh Adler, Esther L German, Elena Mitsi, et al.
BMC Infectious Diseases|November 9, 2016
Understanding pneumococcal serotype 1 biology through population genomic analysisChrispin Chaguza, Jennifer E Cornick, Simon R Harris, et al.
Nature Communications|July 26, 2024
Genomic insights into the 2022-2023Vibrio cholerae outbreak in MalawiChrispin Chaguza, Innocent Chibwe, David Chaima, et al.
The Lancet. Microbe|February 26, 2026
Serotype-specific pneumococcal invasiveness: a global meta-analysis of paired estimates of disease incidence and carriage prevalenceKatherine E Gallagher, Fredrick Odiwour, Christian Bottomley, et al.
The Lancet. Global Health|April 27, 2025
Safety of RTS,S/AS01<sub>E</sub> malaria vaccine up to 1 year after the third dose in Ghana, Kenya, and Malawi (EPI-MAL-003): a phase 4 cohort event monitoring studyValérie Haine, Martina Oneko, Muriel Debois, et al.
Nature Genetics|August 23, 2016
Distinct Salmonella Enteritidis lineages associated with enterocolitis in high-income settings and invasive disease in low-income settingsNicholas A Feasey, James Hadfield, Karen H Keddy, et al.
The Lancet. Global Health|November 9, 2025
Effectiveness of the RTS,S/AS01<sub>E</sub> malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and MalawiLatif Ndeketa, Valérie Haine, Muriel Debois, et al.
Pageof 22

Showing results (201-210 of 211) with videos related to

Sort By:
Pageof 22
PLOS Global Public Health|March 24, 2023
Different clinical features in Malawian outpatients presenting with COVID-19 prior to and during Omicron variant dominance: A prospective observational studyMarah G Chibwana, Herbert W Thole, Cat Anscombe, et al.
Communications Biology|October 9, 2020
Bacterial genome-wide association study of hyper-virulent pneumococcal serotype 1 identifies genetic variation associated with neurotropismChrispin Chaguza, Marie Yang, Jennifer E Cornick, et al.
The New England Journal of Medicine|May 3, 2014
Diagnosis of childhood tuberculosis and host RNA expression in AfricaSuzanne T Anderson, Myrsini Kaforou, Andrew J Brent, et al.
American Journal of Respiratory and Critical Care Medicine|September 17, 2020
Experimental Human Pneumococcal Colonization in Older Adults Is Feasible and Safe, Not ImmunogenicHugh Adler, Esther L German, Elena Mitsi, et al.
BMC Infectious Diseases|November 9, 2016
Understanding pneumococcal serotype 1 biology through population genomic analysisChrispin Chaguza, Jennifer E Cornick, Simon R Harris, et al.
Nature Communications|July 26, 2024
Genomic insights into the 2022-2023Vibrio cholerae outbreak in MalawiChrispin Chaguza, Innocent Chibwe, David Chaima, et al.
The Lancet. Microbe|February 26, 2026
Serotype-specific pneumococcal invasiveness: a global meta-analysis of paired estimates of disease incidence and carriage prevalenceKatherine E Gallagher, Fredrick Odiwour, Christian Bottomley, et al.
The Lancet. Global Health|April 27, 2025
Safety of RTS,S/AS01<sub>E</sub> malaria vaccine up to 1 year after the third dose in Ghana, Kenya, and Malawi (EPI-MAL-003): a phase 4 cohort event monitoring studyValérie Haine, Martina Oneko, Muriel Debois, et al.
Nature Genetics|August 23, 2016
Distinct Salmonella Enteritidis lineages associated with enterocolitis in high-income settings and invasive disease in low-income settingsNicholas A Feasey, James Hadfield, Karen H Keddy, et al.
The Lancet. Global Health|November 9, 2025
Effectiveness of the RTS,S/AS01<sub>E</sub> malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and MalawiLatif Ndeketa, Valérie Haine, Muriel Debois, et al.
Pageof 22